DE1110159B - Process for the preparation of analeptically active N-substituted amino orcamphan derivatives or of their acid addition salts and quaternary ammonium compounds - Google Patents
Process for the preparation of analeptically active N-substituted amino orcamphan derivatives or of their acid addition salts and quaternary ammonium compoundsInfo
- Publication number
- DE1110159B DE1110159B DEM42332A DEM0042332A DE1110159B DE 1110159 B DE1110159 B DE 1110159B DE M42332 A DEM42332 A DE M42332A DE M0042332 A DEM0042332 A DE M0042332A DE 1110159 B DE1110159 B DE 1110159B
- Authority
- DE
- Germany
- Prior art keywords
- heptane
- ether
- phenyl
- reaction
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 N-substituted amino Chemical group 0.000 title claims description 18
- 239000002253 acid Substances 0.000 title claims description 14
- 238000000034 method Methods 0.000 title claims description 12
- 150000003839 salts Chemical class 0.000 title claims description 10
- 150000003856 quaternary ammonium compounds Chemical class 0.000 title claims description 7
- 238000002360 preparation method Methods 0.000 title claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- 239000007868 Raney catalyst Substances 0.000 claims description 4
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims description 4
- 229910000564 Raney nickel Inorganic materials 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 3
- 150000003141 primary amines Chemical class 0.000 claims description 3
- 238000005956 quaternization reaction Methods 0.000 claims description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 239000002168 alkylating agent Substances 0.000 claims description 2
- 229940100198 alkylating agent Drugs 0.000 claims description 2
- 150000008050 dialkyl sulfates Chemical class 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 239000004215 Carbon black (E152) Substances 0.000 claims 1
- 230000029936 alkylation Effects 0.000 claims 1
- 238000005804 alkylation reaction Methods 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 229930195733 hydrocarbon Natural products 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 150000003335 secondary amines Chemical class 0.000 claims 1
- 150000003512 tertiary amines Chemical class 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 72
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 41
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- 239000000243 solution Substances 0.000 description 27
- 150000001875 compounds Chemical class 0.000 description 25
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 24
- 239000002585 base Substances 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 238000001953 recrystallisation Methods 0.000 description 12
- 239000000155 melt Substances 0.000 description 11
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 10
- 238000002844 melting Methods 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- 235000011121 sodium hydroxide Nutrition 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 229910052938 sodium sulfate Inorganic materials 0.000 description 7
- 235000011152 sodium sulphate Nutrition 0.000 description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 5
- 229910003446 platinum oxide Inorganic materials 0.000 description 5
- 239000002262 Schiff base Substances 0.000 description 4
- 150000004753 Schiff bases Chemical class 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 230000003555 analeptic effect Effects 0.000 description 3
- ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- ULTHEAFYOOPTTB-UHFFFAOYSA-N 1,4-dibromobutane Chemical compound BrCCCCBr ULTHEAFYOOPTTB-UHFFFAOYSA-N 0.000 description 2
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 239000002269 analeptic agent Substances 0.000 description 2
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 2
- 229940073608 benzyl chloride Drugs 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- MGNZXYYWBUKAII-UHFFFAOYSA-N cyclohexa-1,3-diene Chemical compound C1CC=CC=C1 MGNZXYYWBUKAII-UHFFFAOYSA-N 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- YKWNUSJLICDQEO-UHFFFAOYSA-N ethoxyethane;propan-2-ol Chemical compound CC(C)O.CCOCC YKWNUSJLICDQEO-UHFFFAOYSA-N 0.000 description 2
- 239000008098 formaldehyde solution Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- ODUJIHDQKMHMCH-UHFFFAOYSA-N 1-(3-phenyl-2-bicyclo[2.2.1]heptanyl)pyrrolidine Chemical compound C1(=CC=CC=C1)C1C2CCC(C1N1CCCC1)C2 ODUJIHDQKMHMCH-UHFFFAOYSA-N 0.000 description 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- HECLRDQVFMWTQS-RGOKHQFPSA-N 1755-01-7 Chemical compound C1[C@H]2[C@@H]3CC=C[C@@H]3[C@@H]1C=C2 HECLRDQVFMWTQS-RGOKHQFPSA-N 0.000 description 1
- PIAOLBVUVDXHHL-UHFFFAOYSA-N 2-nitroethenylbenzene Chemical class [O-][N+](=O)C=CC1=CC=CC=C1 PIAOLBVUVDXHHL-UHFFFAOYSA-N 0.000 description 1
- YESNBFAEPGJCQQ-UHFFFAOYSA-N 2-phenylbicyclo[2.2.1]heptan-3-amine Chemical compound NC1C(C2)CCC2C1C1=CC=CC=C1 YESNBFAEPGJCQQ-UHFFFAOYSA-N 0.000 description 1
- WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical compound BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- ASCLNDIFPOOYAH-UHFFFAOYSA-N N,N-diethyl-3-phenylbicyclo[2.2.1]heptan-2-amine Chemical compound C1(=CC=CC=C1)C1C2CCC(C1N(CC)CC)C2 ASCLNDIFPOOYAH-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003113 alkalizing effect Effects 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- JEPPYVOSGKWVSJ-UHFFFAOYSA-N bicyclo[2.2.1]heptan-3-amine Chemical class C1CC2C(N)CC1C2 JEPPYVOSGKWVSJ-UHFFFAOYSA-N 0.000 description 1
- WGHKYNDIOQMIQQ-UHFFFAOYSA-N bicyclo[2.2.1]heptan-4-amine;hydrochloride Chemical compound Cl.C1CC2CCC1(N)C2 WGHKYNDIOQMIQQ-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- CTVMYAZECFXZLN-UHFFFAOYSA-N camfetamine Chemical compound CNC1C(C2)CCC2C1C1=CC=CC=C1 CTVMYAZECFXZLN-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 description 1
- IKFBPFGUINLYQI-UHFFFAOYSA-N fencamfamin Chemical compound CCNC1C(C2)CCC2C1C1=CC=CC=C1 IKFBPFGUINLYQI-UHFFFAOYSA-N 0.000 description 1
- 235000015244 frankfurter Nutrition 0.000 description 1
- KGZLFTWMCMEEJR-UHFFFAOYSA-N heptane;hydrochloride Chemical compound Cl.CCCCCCC KGZLFTWMCMEEJR-UHFFFAOYSA-N 0.000 description 1
- WEUMBMDSCRAELE-UHFFFAOYSA-N heptane;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCC WEUMBMDSCRAELE-UHFFFAOYSA-N 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- LRPCLTPZMUIPFK-UHFFFAOYSA-N methane;sulfuric acid Chemical compound C.OS(O)(=O)=O LRPCLTPZMUIPFK-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- PIAOLBVUVDXHHL-VOTSOKGWSA-N β-nitrostyrene Chemical compound [O-][N+](=O)\C=C\C1=CC=CC=C1 PIAOLBVUVDXHHL-VOTSOKGWSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
DEUTSCHESGERMAN
PATENTAMTPATENT OFFICE
kl. 12 o 25kl. 12 o 25
INTERNATIONALE KL. INTERNATIONAL KL.
C07c;dC07c; d
M 42332 IVb/12 οM 42332 IVb / 12 ο
BEKANNTMACHUNG
DER ANMELDUNG
UNDAUSGABE DER
AUSLEGESCHRIFT.·NOTICE
THE REGISTRATION
AND ISSUE OF
EDITORIAL. ·
I.August 1959August 1st, 1959
6. JULI 1961JULY 6, 1961
Aus den belgischen Patentschriften 557 666 und 557 667 sind in 5-Stellung alkylsubstituierte 6-Aminobicyclo- [2,2,1 ]-heptane und -heptene bekanntgeworden, die ganglienblockierende Wirkung besitzen. Eine gleichartige Wirkung besitzen die in der deutschen Patentschrift 1 039 061 beschriebenen N-substituierten Derivate des 3-Aminoisocamphans, die in 2-Stellung zwei Methylgruppen tragen und am Stickstoffatom durch niedere Alkylreste substituiert sind. Ferner ist in der deutschen Patentschrift 1 001 257 die Herstellung von blutdrucksteigernden 1,4-Endomethylencyclohexylaminen beschrieben. Außerdem wird in Experientia, Bd. 14, 1958, S. 222, über die blutdrucksenkende und ganglienblockierendeWirkungvonmethylensubstituierten 3-Aminonorcamphanen berichtet.From the Belgian patents 557 666 and 557 667 alkyl-substituted 6-aminobicyclo- [2,2,1] -heptanes and -heptenes have become known, which have ganglion-blocking effects. One The N-substituted compounds described in German Patent 1,039,061 have a similar effect Derivatives of 3-aminoisocamphane which have two methyl groups in the 2-position and on the nitrogen atom are substituted by lower alkyl radicals. Furthermore, in the German patent specification 1 001 257, the production of 1,4-endomethylenecyclohexylamines that increase blood pressure described. In addition, Experientia, Vol. 14, 1958, p. 222, on the antihypertensive and ganglia-blocking effects of methylene-substituted 3-aminonorcamphans have been reported.
Die vorliegende Erfindung betrifft die Herstellung neuer analeptisch wirksamer N-substituierter Aminonorcamphanderivate sowie die Umwandlung dieser Verbindungen in ihre Säureadditionssalze oder quaternären Ammoniumverbindungen.The present invention relates to the preparation of new analeptically active N-substituted amino orcamphan derivatives as well as the conversion of these compounds into their acid addition salts or quaternary Ammonium compounds.
Es wurde gefunden, daß die Verbindungen der allgemeinen Formel IIIt has been found that the compounds of the general formula II
R3 R 3
(CH2);(CH 2 );
Z)XZ) X
n
R2 n
R 2
Verfahrenprocedure
zur Herstellung analeptisch wirksamer
N-substituierter Aminonorcamphanderivateto produce more analeptically effective
N-substituted amino orcamphan derivatives
bzw. von deren Säureadditionssalzen
und quaternären Ammoniumverbindungenor of their acid addition salts
and quaternary ammonium compounds
Anmelder:Applicant:
E. Merck Aktiengesellschaft,
Darmstadt, Frankfurter Str. 250E. Merck Aktiengesellschaft,
Darmstadt, Frankfurter Str. 250
Dipl.-Chem. Dr. Jan Thesing,Dipl.-Chem. Dr. Jan Thesing,
Nieder-Ramstadt-Trautheim über Darmstadt,Nieder-Ramstadt-Trautheim via Darmstadt,
Dipl.-Chem. Dr. Georg Seitz, Dr. med. Rudolf Hotovy und Dr. med. Siegmund Sommer, Darmstadt,Dipl.-Chem. Dr. Georg Seitz, Dr. med. Rudolf Hotovy and Dr. med. Siegmund Sommer, Darmstadt,
sind als Erfinder genannt wordenhave been named as inventors
worin R1 = Aryl, Aralkyl, Cycloalkyl oder ein heterocyclischer Rest und diese Reste funktionell oder durch einen Kohlenwasserstoffrest ein- oder mehrfach substituiert sein können, R2 = H, Alkyl oder Aryl, R3 und R4 = H, Alkyl, Cycloalkyl oder Aralkyl und diese Reste gleich, verschieden oder Bestandteile eines Ringes sein können, der gegebenenfalls weitere Heteroatome enthält, jedoch nicht gleichzeitig beide Reste R3 und R4H oder Methyl bedeuten können, und .v = 1 oder 2 ist, sowie deren Säureadditionssalze und quaternäre Ammoniumverbindungen starke analeptische Wirkung aufweisen, ohne gleichzeitig den Blutdruck zu erhöhen oder die Herztätigkeit zu beeinflussen. Die neuen Verbindungen sind von ausgezeichneter Verträglichkeit und zeigen keinerlei Nebenwirkungen. Gegenüber der aus der Literatur bekannten ähnlichsten Verbindung, dem 2-Phenyl-3-dimethylaminobicyclo-[2,2,l]-heptan, zeigen die erfindungsgemäß hergestellten Verbindungen eine deutliche Wirkungssteigerung. So ist z. B. das 2-Phenyl-where R 1 = aryl, aralkyl, cycloalkyl or a heterocyclic radical and these radicals can be functionally or monosubstituted or polysubstituted by a hydrocarbon radical, R 2 = H, alkyl or aryl, R 3 and R 4 = H, alkyl, cycloalkyl or Aralkyl and these radicals can be the same, different or components of a ring which may contain further heteroatoms, but both radicals R 3 and R 4 cannot be H or methyl at the same time, and .v = 1 or 2, as well as their acid addition salts and quaternary Ammonium compounds have strong analeptic effects without increasing blood pressure or affecting the heart. The new compounds are extremely well tolerated and show no side effects. Compared to the most similar compound known from the literature, 2-phenyl-3-dimethylaminobicyclo- [2.2, l] -heptane, the compounds prepared according to the invention show a significant increase in activity. So is z. B. the 2-phenyl
3-methyläthylaminobicyclo-[2,2,l]-heptan zweimal, das 2-Phenyl-3-äthylaminobicyclo-[2,2,l]-heptan und das 2-Phenyl-3-diäthylaminobicyclo-[2,2,l]-heptan dreimal wirksamer als die bekannte Verbindung.3-methyläthylaminobicyclo- [2.2, l] -heptane twice that 2-phenyl-3-äthylaminobicyclo- [2.2, l] -heptane and 2-phenyl-3-diethylaminobicyclo- [2.2, l] -heptane three times more effective than the known compound.
Ferner wurde gefunden, daß man die neuen Verbindungen herstellen kann, indem man eine Verbindung der allgemeinen Formel IIt has also been found that the new compounds can be made by making a compound of the general formula I.
(CH2),!(CH 2 ) ,!
NH2
R2 NH 2
R 2
worin R1, R2 und χ die oben angegebene Bedeutung besitzen, in an sich bekannter Weise am Stickstoffatom ein- oder mehrfach substituiert und gegebenenfalls die so erhaltenen Verbindungen der allgemeinen Formel II in ihre Säureadditionssalze oder quaternären Ammoniumverbindungen umwandelt.wherein R 1 , R 2 and χ have the meaning given above, monosubstituted or polysubstituted in a manner known per se and optionally converting the compounds of general formula II thus obtained into their acid addition salts or quaternary ammonium compounds.
109 620/44S109 620 / 44S
Das Verfahren nach der Erfindung verläuft nach folgendem Reaktionsschema:The process according to the invention proceeds according to the following reaction scheme:
.Ν:.Ν:
(CH2),(CH 2 ),
IIIIII
R1 bis R4 und x besitzen die angegebene Bedeutung, R5 = Alkyl oder Aralkyl, X = physiologisch unbedenkliches Anion.R 1 to R 4 and x have the meaning given, R 5 = alkyl or aralkyl, X = physiologically harmless anion.
Gegenstand der Erfindung ist somit ein Verfahren zur Herstellung analeptisch wirksamer N-substituierter Aminonorcamphanderivate, das darin besteht, daß man eine Verbindung der allgemeinen Formel I (vgl. Reaktionsschema) nach an sich bekannten Substitutionsmethoden in eine entsprechende, am Stickstoffatom mono- oder disubstituierte Verbindung der allgemeinen Formel II überführt und daß man gegebenenfalls das so hergestellte Amin der allgemeinen Formel II durch Behandlung mit einer Säure in ein Säureadditionssalz der allgemeinen Formel III umwandelt oder nach an sich bekannten Quaternierungsmethoden in eine quaternäre Ammoniumverbindung der allgemeinen Formel IV überführt. The invention therefore relates to a process for the preparation of N-substituted compounds with analeptic activity Aminonorcamphanderivate, which consists in that one compound of the general formula I. (see. Reaction scheme) according to known substitution methods in a corresponding, am Nitrogen atom mono- or disubstituted compound of the general formula II is converted and that one optionally the amine of the general formula II prepared in this way by treatment with a Converts acid into an acid addition salt of the general formula III or according to known methods Quaternization methods in a quaternary ammonium compound of the general formula IV converted.
Die Verbindungen der allgemeinen Formel II können nach allen üblichen Methoden der Substitution von Wasserstoffatomen, die mit einem Stickstoffatom verbunden sind, aus den entsprechenden primären Aminen in an sich bekannter Weise hergestellt werden.The compounds of the general formula II can be substituted by any of the customary methods of hydrogen atoms linked to a nitrogen atom from the corresponding primary amines are prepared in a manner known per se.
So kann man beispielsweise die Verbindungen der allgemeinen Formel I mit Alkyl- oder Aralkylhalogeniden in üblicher Weise in die am Stickstoff mono- oder disubstituierten Verbindungen überführen. Man kann sie ferner mit Aldehyden unter Bildung Schiffscher Basen kondensieren und diese entweder hydrieren oder mit einem Alkylierungsmittel behandeln und anschließend hydrolysieren. Ebenso gelangt man zu den neuen Verbindungen der allgemeinen Formel II, wenn man ein Amin der allgemeinen Formel I mit einem Aldehyd in Gegenwart von Ameisensäure umsetzt. Auch die Umsetzung eines Amins der allgemeinen Formel I mit Alkohol bei Anwesenheit von Raney-Nickel sowie dessen Acylierung und darauffolgende Reduktion, beispielsweise mit Lithiumaluminiumhydrid, können mit gutem Erfolg durchgeführt werden.So you can, for example, the compounds of general formula I with alkyl or aralkyl halides converted in the usual way into the compounds mono- or disubstituted on the nitrogen. One can they also condense with aldehydes to form Schiff bases and either hydrogenate them or treat with an alkylating agent and then hydrolyze. Likewise one arrives at the new compounds of general formula II, if you have an amine of general formula I with an aldehyde in the presence of formic acid. Also the implementation of an amine of the general Formula I with alcohol in the presence of Raney nickel and its acylation and subsequent Reduction, for example with lithium aluminum hydride, can be carried out with good success will.
Durch Behandlung einer Verbindung der allgemeinen Formel II mit einer Säure erhält man die Säureadditionssalze der allgemeinen Formel III. Für diese Umsetzung kommen solche Säuren in Frage, die physiologisch unbedenkliche Salze liefern. Beispielsweise kann man die folgenden Salze herstellen: Chlorid, Orthophosphat, Nitrat, Sulfat, Maleat, Fumarat, Citrat, Tartrat, Oxalat, Methansulfat, Natriumdisulfonat, Hemisuccinat, Propionat, Butyrat und Acetat.The acid addition salts are obtained by treating a compound of the general formula II with an acid of the general formula III. For this implementation, those acids come into question that Deliver physiologically harmless salts. For example, you can make the following salts: Chloride, orthophosphate, nitrate, sulfate, maleate, fumarate, citrate, tartrate, oxalate, methane sulfate, Sodium disulfonate, hemisuccinate, propionate, butyrate and acetate.
Die Herstellung der quaternären Verbindungen der allgemeinen Formel IV kann erfolgen durch Umsetzung einer Verbindung der allgemeinen Formel II mit allen zur Quaternierung geeigneten Verbindungen, z. B. Alkyl- oder Aralkylhalogeniden oder Dialkylsulfat. The quaternary compounds of the general formula IV can be prepared by Implementation of a compound of the general formula II with all compounds suitable for quaternization, z. B. alkyl or aralkyl halides or dialkyl sulfate.
Die als Ausgangsmaterial verwendeten primären Amine kann man in an sich bekannter Weise z. B. nach den Verfahren in J. Am. Chem. Soc, Bd. 61, 1939, S. 521; Bd. 73, 1951, S. 5068, und J. Org. Chem., Bd. 8, 1943, S. 373, durch Dien-Addition von ω-Nitrostyrol bzw. kernsubstituierten und/oder /S-methylierten Nitrostyrolderivaten an Cyclopentadien oder Cyclohexadien und anschließender Hydrierung, die in einem Arbeitsgang oder auch stufenweise erfolgen kann, herstellen. In gleicher Weise kann man an Stelle von Cyclopentadien Dicyclopentadien einsetzen. The primary amines used as starting material can be used in a manner known per se, for. B. following the procedures in J. Am. Chem. Soc, Vol. 61, 1939, p. 521; Vol. 73, 1951, p. 5068, and J. Org. Chem., Vol. 8, 1943, p. 373, by diene addition of ω-nitrostyrene or ring-substituted and / or / S-methylated Nitrostyrene derivatives of cyclopentadiene or cyclohexadiene and subsequent hydrogenation, which in can be done in one operation or in stages. In the same way you can go to Use dicyclopentadiene in place of cyclopentadiene.
In der nachfolgenden Tabelle sind einige der erfindungsgemäß erhältlichen Verbindungen zusammengestellt: Some of the compounds obtainable according to the invention are compiled in the table below:
Sdp. Base (b)M.p. hydrochloride (a)
Bp base (b)
Die neuen Verbindungen können als Analeptica in der Humanmedizin verwendet werden. Da sie weder den Blutdruck erhöhen, noch die Herztätigkeit beeinflussen, kann man die neuen Verbindungen im Gegensatz zu den bisher bekannten Analeptica auch an Hochdruckkranke verabfolgen.The new compounds can be used as analeptics in human medicine. Since they The new compounds can neither increase blood pressure nor affect heart activity In contrast to the previously known analeptics, also administered to hypertensive patients.
Beispiel 1
2-Phenyl-3-methylaminobicyclo-[2,2,1 ]-heptanexample 1
2-phenyl-3-methylaminobicyclo- [2,2,1] -heptane
37,46 g 2-Phenyl-3-aminobicyclo-[2,2,l]-heptan werden mit 22 g Benzaldehyd 10 Minuten auf dem Dampfbad erwärmt. Man befreit die entstandene Schiffsche Base durch Evakuieren von dem bei der Reaktion gebildeten Wasser, mischt sie mit 20 g Dimethylsulfat und erwärmt das Gemisch 4 Stunden auf 80 bis 85° C. Nach dem Erkalten löst man es in Wasser, säuert es mit wenig Salzsäure an und wäscht den entstandenen Benzaldehyd mit Äther aus. Die saure Lösung wird mit Natronlauge alkalisiert und die abgeschiedene Base in Äther aufgenommen. Der Abdampfrückstand des Äthers gibt beim Destillieren 28 g Base vom Sdp. 25 = 158 bis 162° C.37.46 g of 2-phenyl-3-aminobicyclo- [2.2, l] -heptane are heated with 22 g of benzaldehyde for 10 minutes on the steam bath. The Schiff base formed is freed from the water formed in the reaction by evacuation, mixed with 20 g of dimethyl sulfate and the mixture is heated to 80 to 85 ° C. for 4 hours. After cooling, it is dissolved in water and acidified with a little hydrochloric acid and washes off the benzaldehyde produced with ether. The acidic solution is made alkaline with sodium hydroxide solution and the deposited base is taken up in ether. The evaporation residue of the ether gives 28 g of base with bp 25 = 158 to 162 ° C. during distillation.
Das in Essigsäureäthylester mit ätherischer Salzsäure hergestellte Hydrochlorid schmilzt nach dem Umkristallisieren aus Benzol—Petroläther bei 198° C.The hydrochloride prepared in ethyl acetate with ethereal hydrochloric acid melts after Recrystallize from benzene-petroleum ether at 198 ° C.
Beispiel 2
2-Phenyl-3-äthylaminobicyclo-[2,2,1 ]-heptanExample 2
2-phenyl-3-ethylaminobicyclo- [2,2,1] -heptane
a) 28,05 g 2-Phenyl-3-aminobicyclo-[2,2,l]-heptan werden mit 6,9 g Acetaldehyd unter Kühlung vermischt. Man erwärmt das Gemisch noch 20 Minuten auf dem Dampfbad unter Rückfluß und befreit das Reaktionsprodukt im Vakuum bei 60° C vom Wasser. Die rohe Base wird in 300 ecm Methanol gelöst und mit 2 g vorreduziertem Platinoxyd hydriert. Nach Aufnahme der berechneten Wasserstoffmenge destilliert man das Lösungsmittel im Vakuum ab, nimmt den Rückstand in verdünnter Salzsäure auf und schüttelt neutrale Nebenprodukte mit Äther aus. Die wäßrige Lösung wird mit Natronlauge alkalisiert und aus-a) 28.05 g of 2-phenyl-3-aminobicyclo- [2.2, l] -heptane are mixed with 6.9 g of acetaldehyde with cooling. The mixture is refluxed for a further 20 minutes on the steam bath and freed Reaction product in vacuo at 60 ° C from the water. The crude base is dissolved in 300 ecm of methanol and Hydrogenated with 2 g of pre-reduced platinum oxide. After taking up the calculated amount of hydrogen, distilled the solvent is removed in vacuo, the residue is taken up in dilute hydrochloric acid and shaken neutral by-products with ether. The aqueous solution is made alkaline with sodium hydroxide solution and
geäthert. Aus der Ätherlösung gewinnt man 13,2 g Base vom Sdp. 0)1 = 128 bis 131° C.
Das Hydrochlorid schmilzt nach dem Umkristallisieren aus Aceton bei 192° C.etherified. 13.2 g of base with bp 0) 1 = 128 to 131 ° C. are obtained from the ethereal solution.
The hydrochloride melts after recrystallization from acetone at 192 ° C.
b) 25 g 2-Phenyl-3-aminobicyclo-[2,2,l]-heptan werden mit 15 g Raney-Nickel und 75 ecm absolutem Alkohol 15 Stunden unter Rückfluß gekocht. Das Filtrat vom Katalysator neutralisiert man mit verdünnter Salzsäure und engt es im Vakuum bis zur Trockene ein.b) 25 g of 2-phenyl-3-aminobicyclo- [2.2, l] -heptane are combined with 15 g of Raney nickel and 75 ecm absolute Alcohol refluxed for 15 hours. The filtrate from the catalyst is neutralized with dilute Hydrochloric acid and concentrate it to dryness in a vacuum.
Das als Rückstand verbleibende Hydrochlorid wird durch Umkristallisieren aus Aceton oder Dioxan—Petroläther gereinigt. Ausbeute 21,5 g vom Schmp. 1910C.The hydrochloride remaining as residue is purified by recrystallization from acetone or dioxane-petroleum ether. Yield 21.5 g mp. 191 0 C.
Die Verbindung gibt mit der nach a) hergestellten Substanz keine Schmelzpunktsdepression.The compound does not give a depression of the melting point with the substance prepared according to a).
Beispiel 3
2-Phenyl-3-diäthylaminobicyclo-[2,2,1 ]-heptanExample 3
2-phenyl-3-diethylaminobicyclo- [2,2,1] -heptane
3,8 g des nach Beispiel 2 hergestellten 2-Phenyl-3-äthylaminobicyclo-[2,2, 1 ]-heptanhydrochlorids werden mit 20 ecm Pyridin und 3,8 g Essigsäureanhydrid 12 Stunden bei Zimmertemperatur aufbewahrt. Die während des Stehens klar gewordene Lösung wird im Vakuum bis zur Trockene destilliert. Den Rückstand reibt man mit Wasser an, nimmt das Unlösliche in Äther auf und wäscht den Äther mit verdünnter Säure, Bicarbonatlösung und Wasser. Die als Ab-3.8 g of the 2-phenyl-3-äthylaminobicyclo- [2.2, prepared according to Example 2, 1] -heptane hydrochloride with 20 ecm pyridine and 3.8 g acetic anhydride Stored for 12 hours at room temperature. The solution that became clear while standing becomes distilled to dryness in vacuo. The residue is rubbed with water, the insoluble in Ether and washes the ether with dilute acid, bicarbonate solution and water. The as off
dampfrückstand des Äthers erhaltene kristallisierte Acetylverbindung (2,6 g) wird als Rohprodukt weiterverarbeitet. Man löst sie in 20 ecm absolutem Äther und versetzt sie mit einem kleinen Überschuß Lithiumalanat in 25 ecm absolutem Äther. Dann wird das Gemisch 2 Stunden bei Zimmertemperatur gerührt und noch einige Minuten unter Rückfluß gekocht. Die mit 5 g Weinsäure in 50 ecm Wasser vorsichtig versetzte Lösung wird mit Natronlauge stark alkalisiert. Aus dem abgetrennten Äther erhält man die gesuchte Base als Abdampfrückstand. Nach Lösen in Essigsäureäthylester und Zugabe ätherischer Salzsäure erhält man 2,6 g Hydrochlorid, das nach dem Umkristallisieren aus Aceton bei 222° C schmilzt.Crystallized acetyl compound obtained from vapor residue of the ether (2.6 g) is processed further as a crude product. They are dissolved in 20 ecm of absolute ether and a small excess of lithium alanate is added to them in 25 ecm absolute ether. The mixture is then stirred at room temperature for 2 hours and refluxed for a few more minutes. Carefully add 5 g of tartaric acid in 50 ecm of water mixed solution is strongly alkalized with sodium hydroxide solution. From the separated ether one obtains the one we are looking for Base as evaporation residue. After dissolving in ethyl acetate and adding ethereal hydrochloric acid 2.6 g of hydrochloride are obtained, which melts at 222 ° C. after recrystallization from acetone.
7 87 8
Beispiel 4 Beispiel 9Example 4 Example 9
2-Phenyl-3-cyclohexylaminobicyclo-[2,2,1 ]-heptan 2-Phenyl-3-morpholinobicyclo-[2,2,l]-heptan2-phenyl-3-cyclohexylaminobicyclo- [2,2,1] -heptane 2-phenyl-3-morpholinobicyclo- [2,2,1] -heptane
18,7 g 2-Phenyl-3-aminobicyclo-[2,2,l]-heptan wer- Aus 9,35 g 2-Phenyl-3-aminobicyclo-[2,2,l]-heptan18.7 g of 2-phenyl-3-aminobicyclo- [2.2, l] -heptane are made from 9.35 g of 2-phenyl-3-aminobicyclo- [2.2, l] -heptane
den mit 10 g Cyclohexanon 20 Stunden auf 100° C 5 und 7,9 g ß/S'-Dichlordiäthyläther erhält man analogthat with 10 g of cyclohexanone at 100 ° C. for 20 hours and 7.9 g of β / S'-dichlorodiethyl ether are obtained analogously
erwärmt. Man kühlt das Gemisch ab, löst die rohe Beispiel 7 2-Phenyl-3-morpholinobicyclo-[2,2,1]-warmed up. The mixture is cooled and the crude Example 7 2-phenyl-3-morpholinobicyclo- [2,2,1] -
Schiffsche Base in 180 ecm Methanol und hydriert sie heptanhydrochlorid vom Schmelzpunkt 258° C.
nach Zusatz von 2 g vorreduziertem Platinoxyd beiSchiff's base in 180 ecm of methanol and hydrogenated with heptane hydrochloride with a melting point of 258 ° C.
after adding 2 g of pre-reduced platinum oxide
3 atü. Nach 30 Minuten ist die Wasserstoffaufnahme Beispiel 103 atü. After 30 minutes, the hydrogen uptake is Example 10
beendet. Man filtriert den Katalysator ab und erhält io .completed. The catalyst is filtered off and io.
aus dem eingeengten Filtrat nach der Destillation 2-Phenyl-3-benzylammobicyclo-[2,2,l]-heptanfrom the concentrated filtrate after the distillation 2-phen y l-3-benz y lammobicyclo- [2.2, l] -heptane
18,2 g Base vom Sdp.0,05 = 145° C. 74,8 g 2-Phenyl-3-aminobicyclo-[2,2,l]-heptan werden mit 26,6 g Benzylchlorid 8 Stunden auf 155;C18.2 g of base from 0 bp, 05 = 145 ° C. 74.8 g of 2-phenyl-3-aminobicyclo [2,2, l] heptane 26.6 g of benzyl chloride are 8 hours at 155. C.
Beispiel 5 erhitzt. Das erhaltene Reaktionsgemisch reibt manExample 5 heated. The reaction mixture obtained is rubbed
. ,. . .„ „ , 15 mit absolutem Äther an, filtriert, wäscht das Filtrat. ,. . . "", 15 with absolute ether on, filtered, washes the filtrate
2-Phenyl-3-cyclohexylmethylaminobicyclo-[2,2,l]- zweimal mit Wasser und neutralisiert die mit Natrium-2-phenyl-3-cyclohexylmethylaminobicyclo- [2,2, l] - zwe i ma l with water and neutralized with sodium
heptan sulfat getrocknete Ätherlösung mit Salzsäuregas.heptane sulfate dried ethereal solution with hydrochloric acid gas.
10,75 g des nach Beispiel 4 hergestellten 2-Phenyl- Das dabei ausfallende amorphe Hydrochlorid kristal-3-cyclohexylaminobicyclo-[2,2,l]-heptans
werden mit lisiert beim Anreiben mit Aceton. Nach dem Um-5.5 g Ameisensäure und 3,82 ecm 33volumprozentiger 20 kristallisieren aus Isopropylalkohol—Äther beträgt
Formaldehydlösung 4 Stunden auf 100° C erwärmt. der Schmelzpunkt 184° C.
Nach dem Abkühlen wird die Mischung mit verdünnter Natronlauge alkalisiert und ausgeäthert. Beispiel 1110.75 g of the 2-phenyl prepared according to Example 4 The amorphous hydrochloride which precipitates is crystalline 3-cyclohexylaminobicyclo- [2.2, l] -heptane are lysed when rubbed with acetone. After around 5.5 g of formic acid and 3.82 ecm of 33% by volume crystallize from isopropyl alcohol — ether, the formaldehyde solution is heated to 100 ° C for 4 hours. the melting point 184 ° C.
After cooling, the mixture is made alkaline with dilute sodium hydroxide solution and extracted with ether. Example 11
Aus dem Äther erhält man 9,6 g Base vom Sdp. 0,i - n, , , rxT fO , ,..., 1X xr ..,., „ From the ether one receives 9.6 g of base with bp 0 , i - n ,,, rxT fO,, ..., 1X xr ..,., "
= 165" C 25 2-Phenyl-3-[N-(/S-phenylathyl)-N-athyl]-= 165 "C 25 2-phenyl-3- [N - (/ S-phenylethyl) -N-ethyl] -
~ . , aminobicyclo-[2,2,1 !-heptan~. , aminobicyclo- [2,2,1! -heptane
Beispiel 6 J L J v Example 6 JLJ v
, ... ,„„.,,, 21,5g 2-Phenyl-3-äthylaminobicyclo-[2,2,l]-heptan, ..., "". ,,, 21.5 g of 2-phenyl-3-ethylaminobicyclo- [2.2, l] -heptane
2-Phenyl-3-äthylpropylaminobicyclo-[2,2,l]-heptan und 9<25 g ^phenyläthylbromid werden 20 Stunden2-Phenyl-3-äthylpropylaminobicyclo- [2.2, l] -heptane and 9 <25 g ^ phenylethyl bromide are 20 hours
43,07 g des nach Beispiel 2 erhaltenen 2-Phenyl- auf 160° C erhitzt. Man verreibt das abgekühlte43.07 g of the 2-phenyl obtained according to Example 2 are heated to 160.degree. You rub the cooled down
3-äthylaminobicyclo-[2,2,l]-heptans werden mit 12,3 g 30 Reaktionsprodukt mit absolutem Äther, saugt ab,3-äthylaminobicyclo- [2.2, l] -heptans are combined with 12.3 g of reaction product with absolute ether, sucks off,
n-Propylbromid 12 Stunden im Bombenrohr auf wäscht das Filtrat mit Wasser und trocknet mitn-Propyl bromide for 12 hours in a sealed tube, the filtrate washes with water and dries with it
120: C erwärmt. Nach dem Abkühlen verdünnt man Natriumsulfat. Beim Eindampfen der filtrierten Äther-120 : C heated. After cooling, the sodium sulfate is diluted. When evaporating the filtered ethereal
das Gemisch mit absolutem Äther, trennt das aus- lösung kristallisiert die Base aus und schmilzt nachthe mixture with absolute ether separates the solution, the base crystallizes out and melts again
geschiedene 2-Phenyl-3-äthylpropylaminobicyclo-[2,2, dem Umkristallisieren aus Methanol bei 6I0C.
1 ]-heptanhydrobromid ab und schüttelt die Äther- 35divorced 2-phenyl-3-äthylpropylaminobicyclo- [2.2, recrystallization from methanol at 6I 0 C.
1] -heptane hydrobromide and shakes the ether 35
lösung des Reaktionsproduktes mit etwas Essigsäure- Beispiel 12Solution of the reaction product with a little acetic acid - Example 12
anhydrid und so viel Soda, daß das Gemisch alkalisch „ _, , _ „ , ... , , · ,- , r*> -. π ιanhydride and so much soda that the mixture is alkaline "_,, _", ...,, ·, -, r *> -. π ι
bleibt. Aus der Ätherlösung wird die gesuchte Base ^Phenyl^-phenylathylaminobicyclo-^Jl-heptanremain. From the ethereal solution, the sought-after base becomes ^ phenyl ^ -phenylethylaminobicyclo- ^ Jl-heptane
vom Sdp. j = 138" C als Abdampf rückstand erhalten. Analog Beispiel 11 erhält man durch Umsetzungobtained as evaporation residue with bp j = 138 ° C. Analogously to Example 11, reaction is obtained
Das Hydrochlorid schmilzt bei 175° C. 40 von 2-Phenyl-3-äthylaminobicyclo-[2,2,l]-heptan mitThe hydrochloride melts at 175 ° C. 40 of 2-phenyl-3-äthylaminobicyclo- [2.2, l] -heptane with
jS-Phenyläthylchlorid das 2-Phenyl-3-/S-phenyläthyl-jS-phenylethyl chloride 2-phenyl-3- / S-phenylethyl-
Beispiel 7 aminobicyclo- [2,2,1]-heptanhydrochlorid. Schmelzpunkt 254= C nach Umkristallisieren aus Wasser.
2-Phenyl-3-pyrrolidinobicyclo-[2,2,1 ]-heptanExample 7 aminobicyclo- [2,2,1] -heptane hydrochloride. Melting point 254 = C after recrystallization from water.
2-phenyl-3-pyrrolidinobicyclo [2,2,1] heptane
9.35 g 2-Phenyl-3-aminobicyclo-[2,2,l]-heptan wer- 45 Beispiel 139.35 g of 2-phenyl-3-aminobicyclo- [2.2, l] -heptane are 45 Example 13
den mit 11,8 g Tetramethylenbromid und 50 g 10%iger ^-Phenvl-S-iv-diDhenvloroDvn-the one with 11.8 g of tetramethylene bromide and 50 g of 10% iger ^ -Phenvl-S-iv-diDhenvloroDvn-
Natronlauge 10 Stunden unter Rühren am Rückfluß- -SLt 2 ηί?Γ2Sodium hydroxide solution for 10 hours with stirring under reflux -SLt 2 ηί? Γ2
kühler gekocht. Die ölige Base wird nach dem Ab- aminobicyclo-[2,2,l]-heptancooked cooler. The oily base becomes after the abaminobicyclo- [2.2, l] -heptane
kühlen ausgeäthert und aus der Ätherlösung mit ver- 6,25 g /?,/3-Diphenylacrolein werden mit 5,62 gcool and extract from the ethereal solution with 6.25 g /?, / 3-diphenylacrolein with 5.62 g
dünnter Salzsäure extrahiert. Die aus dem Säure- 50 2-Phenyl-3-aminobicyclo-[2,2,l]-heptan in 100 ecmextracted from dilute hydrochloric acid. The from the acid 50 2-phenyl-3-aminobicyclo- [2.2, l] -heptane in 100 ecm
auszug beim Alkalisieren sich abscheidende Base wird Methanol 10 Minuten unter Rückfluß gekocht. Diethe base, which separates out during alkalization, is refluxed for 10 minutes with methanol. the
ausgeäthert und aus dem mit Natriumsulfat getrock- so erhaltene Lösung der Schiffschen Base wird nachetherified and from the solution of the Schiff's base obtained with sodium sulfate dried in this way is after
neten Äther durch Eindampfen gewonnen. Zusatz von 2 g Platinoxyd bei 6 atü und 50° C hydriert,neten ether obtained by evaporation. Addition of 2 g of platinum oxide hydrogenated at 6 atm and 50 ° C,
Man nimmt den Rückstand in Aceton auf, neutrali- wobei die berechnete Wasserstoffaufnahme in wenigen siert ihn mit ätherischer Salzsäure und erhält nach 55 Minuten erfolgt. Aus der vom Katalysator abZugabe von Äther 12,3g rohes 2-Phenyl-3-pyrrolidino- filtrierten Lösung erhält man beim Einengen zur bicyclo-[2,2,l !-heptanhydrochlorid vom Schmelzpunkt Trockne die Base, die mit ätherischer Salzsäure in das 207° C. Beim Umkristallisieren aus Aceton oder Hydrochlorid übergeführt wird. Ausbeute 10,5 g vom Dioxan steigt der Schmelzpunkt auf 216° C. Schmp. 274° C.The residue is taken up in acetone, neutral, with the calculated hydrogen uptake in a few Sizes it with essential hydrochloric acid and gets done after 55 minutes. From the addition of the catalyst of ether 12.3g of crude 2-phenyl-3-pyrrolidino-filtered solution is obtained on concentration to bicyclo- [2.2, l! -heptane hydrochloride from the melting point. Dry the base, which is converted into the 207 ° C. When recrystallizing from acetone or hydrochloride is converted. Yield 10.5 g of Dioxane, the melting point rises to 216 ° C. Mp. 274 ° C.
60 Beispiel 14 60 Example 14
Beispiel 8 2-Phenyl-3-(l'-*-methylnaphthyl)- Example 8 2-Phenyl-3- (l '- * - methylnaphthyl) -
2-Phenyl-3-piperidinobicyclo-[2,2,1 ]-heptan aminobicyclo-[2,2,1 ]-heptan2-phenyl-3-piperidinobicyclo- [2.2.1] -heptane aminobicyclo- [2.2.1] -heptane
Analog Beispiel 7 erhält man durch Umsetzung 19,4 g 2-Phenyl-3-aminobicyclo-[2,2,l]-heptan wer-Analogously to Example 7, 19.4 g of 2-phenyl-3-aminobicyclo- [2.2, l] -heptane are obtained by reaction
von 9,35 g 2-Phenyl-3-aminobicyclo-[2,2,l]-heptan mit 65 den mit 9,3 g «-Chlormethylnaphthalin in 130 ecmof 9.35 g of 2-phenyl-3-aminobicyclo- [2.2.1] -heptane with 65 den with 9.3 g of -chloromethylnaphthalene in 130 ecm
12,65 g Pentamethylenbromid 2-Phenyl-3-piperidino- Toluol 20 Stunden unter Rückfluß gekocht. Die12.65 g of pentamethylene bromide 2-phenyl-3-piperidino-toluene boiled under reflux for 20 hours. the
bicyclo-[2,2,1 !-heptanhydrochlorid, das nach dem abgekühlte Toluollösung wird mit Wasser gewaschen,bicyclo- [2,2,1! -heptane hydrochloride, which after the cooled toluene solution is washed with water,
Umkristallisieren aus Aceton bei 222° C schmilzt. getrocknet und das Toluol abdestilliert. Den Rück-Recrystallize from acetone at 222 ° C melts. dried and the toluene was distilled off. The back
•5• 5
stand lösf man in;lsöpro>ylälkohöl und neutralisiert ihn mit ätherischer Salzsäure, Es kristallisieret 12 g Hydrochloride aus,; die pach dem 'Umkristallisieren aus Isopropylalköhöl—Äther bei 177° C schmelzen.stand you solve in ; Isopro> yl alcohol oil and neutralizes it with essential hydrochloric acid. 12 g of hydrochloride crystallizes out; which melt after recrystallization from isopropyl alcohol ether at 177 ° C.
2-Phenyl-3-N-(l '-«-methylnaphthyl)-N-methylaminobicyclo-[2,2,l]-heptan 2-phenyl-3-N- (l '- «- methylnaphthyl) -N-methylaminobicyclo- [2,2,1] -heptane
6.0 g 2-Phenyl-3-(l '-«-methylnaphthyty-aminobicyclo- ίο [2,2,l]-heptanhydrochlorid werden mit 1,84 g Formaldehydlösung (30%ig), 1,13 g Natriumformiat, 1,53 g Ameisensäure und 3 ecm absolutem Alkohol 15 Stunden auf 90 bis 100° C erhitzt. Man destilliert den Alkohol ab, nimmt den Rückstand in etwas Wasser auf und alkalisiert die Lösung mit Natronlauge. Die ausfallende Base, wird ausgeäthert, die Ätherlösung mit Natriumsulfat getrocknet, filtriert und der Äther abdestilliert. Den Rückstand löst man in Essigsäureäthylester und neutralisiert ihn mit ätherischer Salzsäure, wobei 4,3 g Hydrochlorid erhalten werden, dessen Schmelzpunkt nach dem Umkristallisieren 243° C beträgt.6.0 g of 2-phenyl-3- (l '- «- methylnaphthyty-aminobicyclo- ίο [2.2, l] -heptane hydrochloride are mixed with 1.84 g of formaldehyde solution (30%), 1.13 g of sodium formate, 1.53 g Formic acid and 3 ecm of absolute alcohol heated to 90 to 100 ° C for 15 hours. One distills the Alcohol is removed, the residue is taken up in a little water and the solution is made alkaline with sodium hydroxide solution. The precipitating base is extracted with ether, the ether solution is dried with sodium sulfate, filtered and the Ether distilled off. The residue is dissolved in ethyl acetate and neutralized with ethereal Hydrochloric acid, 4.3 g of hydrochloride being obtained, the melting point of which after recrystallization 243 ° C.
Beispiel 16
2-p-Cumyl-3-äthylaminobicyclo-[2,2,1 ]-heptanExample 16
2-p-cumyl-3-ethylaminobicyclo- [2,2,1] -heptane
5.1 g p-Cumyl-3-aminobicyclo- [2,2,1 ]-heptan werden mit 1 g Raney-Nickel in 20 ecm absolutem Alkohol 48 Stunden unter Rückfluß und Rühren gekocht. Man filtriert die Lösung vom Katalysator ab, wäscht ihn mit Alkohol nach und dampft den Alkohol aus dem Filtrat ab. Der Rückstand wird in 100 ecm Äther gelöst und mit verdünnter Essigsäure erschöpfend ausgeschüttelt. Die durch Alkalisieren der Essigsäureauszüge in Freiheit gesetzte Base nimmt man in Äther auf, trocknet die Ätherlösung mit Natriumsulfat und säuert sie mit ätherischer Salzsäure an. Nach längerem Stehen werden die ausgeschiedenen Kristalle abgesaugt, mit Äther gewaschen und getrocknet. Man erhält 4,8 g Hydrochlorid, das nach dem Umkristallisieren aus Alkohol—Äther bei 206 bis 207° C schmilzt.5.1 g of p-cumyl-3-aminobicyclo- [2,2,1] -heptane become boiled with 1 g of Raney nickel in 20 ecm of absolute alcohol for 48 hours under reflux and stirring. The solution is filtered off from the catalyst, it is washed with alcohol and the alcohol is evaporated off the filtrate. The residue is dissolved in 100 ecm of ether and exhausted with dilute acetic acid shaken out. The base set free by alkalizing the acetic acid extracts is taken in ether up, dries the ethereal solution with sodium sulfate and acidifies it with ethereal hydrochloric acid. To If you stand for a long time, the precipitated crystals are suctioned off, washed with ether and dried. 4.8 g of hydrochloride are obtained, which after recrystallization from alcohol-ether at 206 to 207 ° C melts.
Beispiel 17
2-(p-Cumyl)-3-benzylaminobicyclo- [2,2,1 ]-heptanExample 17
2- (p-Cumyl) -3-benzylaminobicyclo- [2,2,1] -heptane
4545
2,6 g 2 - (p - Cumyl) - 3 - aminobicyclo -[2,2,I]- heptan werden mit 0,81 g Benzylchlorid 8 Stunden auf 1550C erhitzt. Das abgekühlte Reaktionsgemisch nimmt man in Äther auf und wäscht es mehrmals mit Wasser. Der Ätherlösung wird das Reaktionsprodukt durch mehrmaliges Ausschütteln mit 100/oiger Essigsäure entzogen. Die essigsauren Auszüge alkalisiert man mit Natronlauge und äthert sie aus. Aus der mit Natriumsulfat getrockneten und etwas eingeengten Ätherlösung erhält man das Hydrochlorid beim Neutralisieren mit ätherischer Salzsäure. Es läßt sich aus absolutem Alkohol unter Zusatz 'von Äther Umkristallisieren und schmilzt bei 2110C. Die Ausbeute beträgt 1,0 g.2.6 g of 2 - (p - cumyl) - 3 - aminobicyclo - heptane with 0.81 g of benzyl chloride 8 hours to 155 0 C heated - [2,2, I]. The cooled reaction mixture is taken up in ether and washed several times with water. The ether solution is the reaction product extracted by repeated shaking with 10 0 / cent acetic acid. The acetic acid extracts are made alkaline with caustic soda and etherified. The hydrochloride is obtained from the ethereal solution, dried with sodium sulphate and slightly concentrated, when neutralized with ethereal hydrochloric acid. It can be recrystallized from absolute alcohol with the addition of ether and melts at 211 ° C. The yield is 1.0 g.
2-p-Äthoxyphenyl-3-butylaminobicyclo-[2,2,l]-heptan2-p-Ethoxyphenyl-3-butylaminobicyclo- [2.2.1] -heptane
7 g 2-p-Äthoxyphenyl-3-aminobicyclo-[2,2,l]-heptan werden mit 2,2 g n-Butyraldehyd vermischt und 20 Minuten auf 1000C erhitzt. Die gebildete Schiffsche Base löst man in 100 ecm Methanol und schüttelt sie nach Zugabe von 1 g Platinoxyd unter Wasserstoff. Wenn die Wasserstoffaufnahme beendet ist,wird der Katalysator abfiltriert, das Filtrat im Vakuum'1 zur Trockne verdampft, der Rückstand in Wasser aufgenommen, mit Natronlauge alkalisiert und ausgeäthert. Die Ätherlösung trocknet man mit Natriumsulfat, filtriert sie und destilliert den Äther ab. Als Rückstand verbleiben 5 g Base, die in Alkohol gelöst und durch Neutralisieren mit ätherischer Salzsäure in das Hydrochlorid übergeführt werden. Es kristallisiert zunächst eine geringe Menge nichtumgesetztes 2-(p-Äthoxyphenyl) - 3 - aminobicyclo -[2,2,I]- heptanhydrochlorid vom Schmelzpunkt 2080C aus, die abfiltriert wird. Beim Einengen des Filtrats und erneuter Zugabe von absolutem Äther erhält man 3,0 g 2-(p-Äthoxyphenyty-S-butylaminobicyclo-P^lJ-heptanhydrochlorid, das nach dem Umkristallisieren aus Alkohol— Äther bei 1750C schmilzt.7 g 2-p-ethoxyphenyl-3-aminobicyclo [2,2, l] -heptane are with 2.2 g of n-butyraldehyde and heated 20 minutes 100 0 C. The formed Schiff base is dissolved in 100 ecm of methanol and shaken under hydrogen after adding 1 g of platinum oxide. When the hydrogen uptake is complete, the catalyst is filtered off, the filtrate evaporated in vacuo '1 dryness, the residue taken up in water, alkalized with sodium hydroxide and extracted with ether. The ether solution is dried with sodium sulphate, filtered and the ether is distilled off. The residue left is 5 g of base, which are dissolved in alcohol and converted into the hydrochloride by neutralizing with ethereal hydrochloric acid. It first crystallized, a small amount of unreacted 2- (p-ethoxyphenyl) - 3 - aminobicyclo - [2,2, I] - heptane hydrochloride of melting point 208 0 C, which is filtered off. Upon concentration of the filtrate and re-addition of absolute ether to obtain 3.0 g of 2- (p-Äthoxyphenyty-S-P-butylaminobicyclo ^ lJ-heptane hydrochloride which melts after recrystallization from alcohol ether at 175 0 C.
2-(o-Fluorphenyl)-3-pyrrolidinobicyclo-[2,2,l]-heptan 2- (o-Fluorophenyl) -3-pyrrolidinobicyclo- [2.2.1] -heptane
a) 6,05 g 2-(o-Fluorphenyl)-3-aminobicyclo-[2,2, l]-heptanhydrochlorid werden mit 5,9 g Tetramethylenbromid und 34 g 10%iger Natronlauge 15 Stunden unter Rühren und Rückfluß gekocht. Sodann versetzt man das Reaktionsgemisch mit etwas mehr Alkali und äthert es aus. Der Abdampfrückstand der mit Natriumsulfat getrockneten Ätherlösung wird in Aceton gelöst und mit ätherischer Salzsäure neutralisiert. Man erhält 6 g Hydrochlorid, das nach dem Umkristallisieren aus Aceton—Äther bei 2060C schmilzt.a) 6.05 g of 2- (o-fluorophenyl) -3-aminobicyclo- [2.2, l] -heptane hydrochloride are refluxed with 5.9 g of tetramethylene bromide and 34 g of 10% sodium hydroxide solution for 15 hours while stirring. A little more alkali is then added to the reaction mixture and it is etherified. The evaporation residue of the ether solution dried with sodium sulphate is dissolved in acetone and neutralized with ethereal hydrochloric acid. 6 g of hydrochloride are obtained, which melts at 206 ° C. after recrystallization from acetone-ether.
b) Versetzt man eine ätherische Lösung von 2,1 g 2-(o-Fluorphenyl)-3-pyrrolidinobicyclo-[2,2,l]-heptan mit 1,9 g Methyljodid, so kristallisieren beim Stehen 2,5 g Jodmethylat aus; nach dem Umkristallisieren aus Alkohol—-Äther beträgt der Schmelzpunkt 131° C.b) An ethereal solution of 2.1 g of 2- (o-fluorophenyl) -3-pyrrolidinobicyclo- [2.2, l] -heptane is added with 1.9 g of methyl iodide, 2.5 g of iodine methylate crystallize out on standing; after recrystallization from alcohol - ether the melting point is 131 ° C.
2-(m-Xylyl)-3-cyclohexylaminobicyclo-[2,2,1 ]-heptan2- (m-xylyl) -3-cyclohexylaminobicyclo- [2,2,1] -heptane
8,5 g 2 - (m - Xylyl) - 3 - aminobicyclo - [2,2,1 ] - heptan werden mit 3,9 g Cyclohexanon einige Stunden auf 100°C erhitzt. Man löst die gebildete Schiffsche Base in 100 ecm Methanol und schüttelt nach Zugabe von 1 g Platinoxyd unter Wasserstoff bis zur Beendigung der Wasserstoffaufnahme. Der Katalysator wird abfiltriert, das Filtrat eingeengt, die zurückbleibende ölige Base (4,8 g) in Essigsäureäthylester gelöst und mit ätherischer Salzsäure neutralisiert. Das sich abscheidende Hydrochlorid schmilzt nach dem Umkristallisieren aus Essigsäureäthylester bei 229 0C.8.5 g of 2 - (m - xylyl) - 3 - aminobicyclo - [2.2.1] - heptane are heated to 100 ° C. with 3.9 g of cyclohexanone for a few hours. The Schiff base formed is dissolved in 100 ecm of methanol and, after 1 g of platinum oxide has been added, it is shaken under hydrogen until the uptake of hydrogen has ceased. The catalyst is filtered off, the filtrate is concentrated, the remaining oily base (4.8 g) is dissolved in ethyl acetate and neutralized with ethereal hydrochloric acid. The hydrochloride which separates out melts after recrystallization from ethyl acetate at 229 ° C.
Claims (1)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEM42332A DE1110159B (en) | 1959-08-01 | 1959-08-01 | Process for the preparation of analeptically active N-substituted amino orcamphan derivatives or of their acid addition salts and quaternary ammonium compounds |
| CH779260A CH385196A (en) | 1959-08-01 | 1960-07-08 | Process for the preparation of analeptically active N-substituted amino orcamphan derivatives |
| BE593463A BE593463A (en) | 1959-08-01 | 1960-07-27 | Process for the preparation of N-substituted amino-norcamphan derivatives with analeptic activity. |
| GB2631360A GB913866A (en) | 1959-08-01 | 1960-07-28 | Improvements in or relating to amino-norcamphane compounds |
| SE743760A SE302957B (en) | 1959-08-01 | 1960-08-01 | |
| DEM46811A DE1201338B (en) | 1959-08-01 | 1960-10-13 | Process for the preparation of analeptically active N-substituted aminobicyclo-heptane derivatives or of their acid addition salts and quaternary ammonium compounds |
| FR834659A FR978M (en) | 1959-08-01 | 1960-10-24 | |
| CH942461A CH419105A (en) | 1959-08-01 | 1961-08-11 | Process for the preparation of analeptically active N-substituted amino-norcamphanderivate or of their acid addition salts and quaternary ammonium compounds |
| FR873190A FR25F (en) | 1959-08-01 | 1961-09-14 | N-substituted amino norcamphane derivatives with analeptic action. |
| GB35384/61A GB968714A (en) | 1959-08-01 | 1961-09-29 | Analeptically active n-substituted amino-norcamphane derivatives and their addition salts with acids and their quaternary ammonium compounds |
| US143578A US3164601A (en) | 1959-08-01 | 1961-10-09 | Analeptically active n-substituted aminonorcamphane derivatives and their acid addition salts and quaternary ammonium compounds |
| BE609074A BE609074R (en) | 1959-08-01 | 1961-10-12 | Process for the preparation of N-substituted amino-norcamphan derivatives with analeptic activity |
| SE10126/61A SE310175B (en) | 1959-08-01 | 1961-10-12 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEM42332A DE1110159B (en) | 1959-08-01 | 1959-08-01 | Process for the preparation of analeptically active N-substituted amino orcamphan derivatives or of their acid addition salts and quaternary ammonium compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1110159B true DE1110159B (en) | 1961-07-06 |
Family
ID=7304304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DEM42332A Pending DE1110159B (en) | 1959-08-01 | 1959-08-01 | Process for the preparation of analeptically active N-substituted amino orcamphan derivatives or of their acid addition salts and quaternary ammonium compounds |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE593463A (en) |
| CH (1) | CH385196A (en) |
| DE (1) | DE1110159B (en) |
| FR (1) | FR978M (en) |
| GB (1) | GB913866A (en) |
| SE (1) | SE302957B (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3164601A (en) * | 1959-08-01 | 1965-01-05 | Merck Ag E | Analeptically active n-substituted aminonorcamphane derivatives and their acid addition salts and quaternary ammonium compounds |
| DE1219478B (en) | 1960-12-23 | 1966-06-23 | Merck Ag E | Process for the preparation of analeptically active N-substituted amino orcamphan derivatives or of their acid addition salts and quaternary ammonium compounds |
| US3308160A (en) * | 1963-06-26 | 1967-03-07 | Du Pont | 4-phenylbicyclo[2.2.2]octane-1-amines and salts thereof |
| US3341402A (en) * | 1965-01-15 | 1967-09-12 | Smith Kline French Lab | Anti-viral composition and method |
| US3362878A (en) * | 1966-08-01 | 1968-01-09 | Du Pont | Pharmaceutical compositions and methods utilizing substituted bicyclo[2.2.2]-octanes |
| DE2003744A1 (en) * | 1969-02-06 | 1970-09-03 | Colgate Palmolive Co | 3-Amino-2-bicyclo [2.2.2] to octan-2-ols disubstituted in the 3- and 4-positions and process for their preparation |
| DE19835766C2 (en) * | 1998-08-07 | 2003-07-03 | Bosch Gmbh Robert | Arrangement for wiring an electrochemical sensor |
| RU2307826C1 (en) * | 2006-05-30 | 2007-10-10 | Государственное образовательное учреждение высшего профессионального образования Волгоградский государственный технический университет (ВолгГТУ) | Method for production of n-(3-phenyl-2-norcamphanyl)-n-etnylamine hydrochloride |
| US11840495B2 (en) | 2020-12-23 | 2023-12-12 | The Broad Institute, Inc. | Compositions and methods related to di-substituted bicyclo[2.2.1] heptanamine-containing compounds |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1298527B (en) * | 1962-06-09 | 1969-07-03 | Knoll Ag | Process for the preparation of bicyclically substituted aminoalkanes |
| DE1284421B (en) * | 1962-06-09 | 1968-12-05 | Knoll Ag | Bicyclically substituted aminoalkanes and processes for their preparation |
| JP6983161B2 (en) | 2015-09-15 | 2021-12-17 | プラクシス・バイオリサーチ・エルエルシー | Fencanfamin prodrug |
-
1959
- 1959-08-01 DE DEM42332A patent/DE1110159B/en active Pending
-
1960
- 1960-07-08 CH CH779260A patent/CH385196A/en unknown
- 1960-07-27 BE BE593463A patent/BE593463A/en unknown
- 1960-07-28 GB GB2631360A patent/GB913866A/en not_active Expired
- 1960-08-01 SE SE743760A patent/SE302957B/xx unknown
- 1960-10-24 FR FR834659A patent/FR978M/fr not_active Expired
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3164601A (en) * | 1959-08-01 | 1965-01-05 | Merck Ag E | Analeptically active n-substituted aminonorcamphane derivatives and their acid addition salts and quaternary ammonium compounds |
| DE1201338B (en) | 1959-08-01 | 1965-09-23 | Merck Ag E | Process for the preparation of analeptically active N-substituted aminobicyclo-heptane derivatives or of their acid addition salts and quaternary ammonium compounds |
| DE1219478B (en) | 1960-12-23 | 1966-06-23 | Merck Ag E | Process for the preparation of analeptically active N-substituted amino orcamphan derivatives or of their acid addition salts and quaternary ammonium compounds |
| US3308160A (en) * | 1963-06-26 | 1967-03-07 | Du Pont | 4-phenylbicyclo[2.2.2]octane-1-amines and salts thereof |
| US3341402A (en) * | 1965-01-15 | 1967-09-12 | Smith Kline French Lab | Anti-viral composition and method |
| US3362878A (en) * | 1966-08-01 | 1968-01-09 | Du Pont | Pharmaceutical compositions and methods utilizing substituted bicyclo[2.2.2]-octanes |
| DE2003744A1 (en) * | 1969-02-06 | 1970-09-03 | Colgate Palmolive Co | 3-Amino-2-bicyclo [2.2.2] to octan-2-ols disubstituted in the 3- and 4-positions and process for their preparation |
| DE19835766C2 (en) * | 1998-08-07 | 2003-07-03 | Bosch Gmbh Robert | Arrangement for wiring an electrochemical sensor |
| RU2307826C1 (en) * | 2006-05-30 | 2007-10-10 | Государственное образовательное учреждение высшего профессионального образования Волгоградский государственный технический университет (ВолгГТУ) | Method for production of n-(3-phenyl-2-norcamphanyl)-n-etnylamine hydrochloride |
| US11840495B2 (en) | 2020-12-23 | 2023-12-12 | The Broad Institute, Inc. | Compositions and methods related to di-substituted bicyclo[2.2.1] heptanamine-containing compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| SE302957B (en) | 1968-08-12 |
| CH385196A (en) | 1964-12-15 |
| BE593463A (en) | 1961-01-27 |
| GB913866A (en) | 1962-12-28 |
| FR978M (en) | 1961-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2513916C2 (en) | N- (2-piperidylmethyl) -2,5-bis (2,2,2-trifluoroethoxy) benzamide | |
| DE1443599A1 (en) | Unsaturated amines | |
| DE1275069B (en) | 1- (3 ', 5'-dihydroxyphenyl) -1-hydroxy-2-isopropylaminoalkanes and processes for their preparation | |
| CH621115A5 (en) | ||
| DE2334404A1 (en) | ALKYL AND CYCLOALKYLTHIOPHENYL ALKYLAMINO ALCOHOLS AND THEIR SALT AND THE PROCESS OF THEIR PRODUCTION | |
| DE2461604C2 (en) | ||
| DE1110159B (en) | Process for the preparation of analeptically active N-substituted amino orcamphan derivatives or of their acid addition salts and quaternary ammonium compounds | |
| DE1080563B (en) | Process for the preparation of diquaternary salts of alkylenediamines | |
| DE1201338B (en) | Process for the preparation of analeptically active N-substituted aminobicyclo-heptane derivatives or of their acid addition salts and quaternary ammonium compounds | |
| DE1294961B (en) | Process for the preparation of 22-azacholestane derivatives and their acid addition salts | |
| DE1802297C3 (en) | Isopropylamine derivatives and processes for their preparation | |
| CH637108A5 (en) | Process for preparing novel 1-aryloxy-2-hydroxy-3-aminopropanes | |
| DE2458624A1 (en) | 3-(4-Ureido-2-acylphenoxy)-2-hydroxy-propylamines - cardioselective beta-adrenergic blocking agents | |
| DE2122259A1 (en) | Alpha-aminoalkyl-4-hydroxy-3-carboalkoxyaminobenzyl alcohols, their acid addition salts, processes for their production and medicinal products | |
| DE1110160B (en) | Process for the preparation of analeptically active N-substituted amino orcamphan derivatives or of their acid addition salts and quaternary ammonium compounds | |
| DE1191381B (en) | Process for the preparation of 2- [5 ', 6', 7 ', 8'-tetrahydronaphthyl- (1') -amino] -imidazoline and its salts | |
| AT256816B (en) | Process for the preparation of new substituted 1-phenyl-2-aminoalkanols and their acid addition salts | |
| AT219020B (en) | Process for the preparation of new N-substituted amino-norcamphanderivaten and their acid addition salts and quaternary ammonium compounds | |
| DD144764A5 (en) | PROCESS FOR PREPARING R-N- (2-PHENYL-2-HYDROXYETHYL) -3-PHENYLPROPYLAMINES | |
| DE1670143C3 (en) | ||
| DE2515548A1 (en) | QUATERNAERE AMMONIUM SALTS OF N-DIALKYLAMINOALKYL-N- (2-INDANYL) -ANILINES AND METHOD FOR THEIR PRODUCTION | |
| DE2224539C3 (en) | ||
| DD149664A5 (en) | PROCESS FOR PRODUCING 1,1'-BIPHENYL-2-YL-ALKYLAMINE DERIVATIVES | |
| AT238180B (en) | Process for the preparation of new pyrrolidine compounds | |
| AT238181B (en) | Process for the preparation of new pyrrolidine compounds |